In addition, we have taken into account the role of the apelinergic system in the most common pregnancy pathologies—PE, IUGR, and GDM—along with the determination of the molecular mechanisms of action of apelin and ELABELA in pregnancy. This evidence concerns the gene APELA and fetal growth restriction.